Myomo (MYO) EBT Margin Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,538.00 |
| Jun 30, 2025 | -3,305.00 |
| Mar 31, 2025 | 6,612.00 |
| Dec 31, 2024 | -7,793.00 |
| Sep 30, 2024 | 2,946.00 |
| Jun 30, 2024 | 368.00 |
| Mar 31, 2024 | -2,449.00 |
| Dec 31, 2023 | 19,171.00 |
| Sep 30, 2023 | 3,169.00 |
| Jun 30, 2023 | 6,219.00 |
| Mar 31, 2023 | -468.00 |
| Dec 31, 2022 | 1,380.00 |
| Sep 30, 2022 | -2,432.00 |
| Jun 30, 2022 | 466.00 |
| Mar 31, 2022 | 5,471.00 |
| Dec 31, 2021 | -33,241.00 |
| Sep 30, 2021 | 9,765.00 |
| Jun 30, 2021 | 29,877.00 |
| Mar 31, 2021 | 25,156.00 |
| Dec 31, 2020 | 42,270.00 |
| Sep 30, 2020 | 31,556.00 |
| Jun 30, 2020 | -9,130.00 |
| Mar 31, 2020 | -6,407.00 |
| Dec 31, 2019 | 17,984.00 |
| Sep 30, 2019 | -2,231.00 |
| Jun 30, 2019 | 12,485.00 |
| Mar 31, 2019 | 44,079.00 |
| Dec 31, 2018 | 199,827.00 |
| Sep 30, 2018 | -13,471.00 |
| Jun 30, 2018 | 26,188.00 |
| Mar 31, 2018 | 752,488.00 |
| Dec 31, 2017 | -196,892.00 |
| Sep 30, 2017 | 15,854.00 |
| Jun 30, 2017 | -43,517.00 |